Last reviewed · How we verify
Ferrous sulfate + folic acid — Competitive Intelligence Brief
marketed
Nutritional supplement / hematologic agent
Hematology / Nutritional deficiency
Small molecule
Live · refreshed every 30 min
Target snapshot
Ferrous sulfate + folic acid (Ferrous sulfate + folic acid) — Ifakara Health Institute. Ferrous sulfate provides bioavailable iron to treat iron deficiency anemia, while folic acid (vitamin B9) supports red blood cell formation and DNA synthesis.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Ferrous sulfate + folic acid TARGET | Ferrous sulfate + folic acid | Ifakara Health Institute | marketed | Nutritional supplement / hematologic agent |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Nutritional supplement / hematologic agent class)
- Ifakara Health Institute · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Ferrous sulfate + folic acid CI watch — RSS
- Ferrous sulfate + folic acid CI watch — Atom
- Ferrous sulfate + folic acid CI watch — JSON
- Ferrous sulfate + folic acid alone — RSS
- Whole Nutritional supplement / hematologic agent class — RSS
Cite this brief
Drug Landscape (2026). Ferrous sulfate + folic acid — Competitive Intelligence Brief. https://druglandscape.com/ci/ferrous-sulfate-folic-acid. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab